Affiliation:
1. School of Pharmacy, North of Si Chuan Medical College, Nan Chong, Si Chuan, China
2. Basic Medical College, North of Si Chuan Medical College, Nan Chong, Si Chuan, China
Abstract
This study aimed to investigate the inhibitory effect of 12-epi-napelline on leukemia cells and its possible mechanisms. The inhibitory effects of 12-epi-napelline on K-562 and HL-60 cells were evaluated using the CCK-8 assay, cell cycle arrest and apoptosis were detected by flow cytometry, and the expression of related proteins was measured by western blot. A K-562 tumor model was established to evaluate the antitumor effect of 12-epi-napelline in vivo. A reduction in leukemia cell viability was observed after treatment with 12-epi-napelline. It was determined that the cell cycle was arrested in the G0/G1 phase, and the cell apoptosis rate was increased. Moreover, caspase-3 and Bcl-2 were downregulated, whereas cleaved caspase-3 and caspase-9 were upregulated. Further study revealed that 12-epi-napelline could suppress the expression of PI3K, AKT, p-AKT, and mTOR. Insulin-like growth factor 1 (IGF-1) attenuated 12-epi-napelline-induced apoptosis and ameliorated the repression of PI3K, AKT, p-AKT, and mTOR by 12-epi-napelline. Animal experiments clearly showed that 12-epi-napelline inhibited tumor growth. In conclusion, 12-epi-napelline restrained leukemia cell proliferation by suppressing the PI3K/AKT/mTOR pathway in vitro and in vivo.
Funder
Strategic Cooperation Research Project of Nanchong
Subject
Complementary and alternative medicine
Reference30 articles.
1. Estimates of cancer incidence and mortality in China, 2013;Z. Rongshou;Chinese Journal of Cancer,2017
2. Breast Cancer Survivorship Guidelines
3. Advances in the treatment of haematological malignancies: optimal sequence of CML treatment
4. Synergistic effect of Baicalin and adriamycin in resistant HL-60/ADM leukemia cells;J. Zheng;Cellular Physiology and Biochemistry,2017
5. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway;K. N. Lin;Biomedicine and Pharmacotherapy,2020